🇺🇸 FDA
Pipeline program

2 mg Melatonin

NMCSD.2015.0048

Phase 3 small_molecule completed

Quick answer

2 mg Melatonin for Anxiety is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Anxiety
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials